计算溶液所需的质量、体积或浓度。
| 活性类型 | Relation | Activity value | Units | Action Type | 期刊 | PubMed Id | doi | Assay Aladdin ID |
|---|
提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
充氩,干燥,-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Alisporivir (Debio-025) is a cyclophilin inhibitor molecule with potent anti-hepatitis C virus ( HCV ) activity.
In Vitro
DEB025 binds to CypA, a peptidyl-prolyl cis-trans isomerase which is a crucial cofactor for HCV replication. Alisporivir (Debio-025) represents the prototype of a new class of non-immunosuppressive cyclophilin inhibitors. Alisporivir prevents HCV protein-mediated collapse of the respiration-driven mitochondrial membrane potential. Alisporivir prevents HCV protein-mediated mitochondrial dysfunction outside the context of apoptosis, calcium overload, production of ROS, dysfunction. In cell culture models, low-micromolar doses of alisporivir block SARS-CoV and MERS-CoV replication. Combination treatment with Alisporivir and ICN-1229 increases the anti-MERS-CoV activity in cell culture. Alisporivir pretreatment stimulates antigen presentation by hepatoma target cells, leading to enhancement of antigen-specific CD8+ T cell activation by 40%. Alisporivir induces an increase of MHC-I and beta-2 microglobulin on the surface of several cell lines . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Combination treatment with Alisporivir and ICN-1229 does not protect against SARS-CoV infection in a mouse model. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Assay
Alisporivir is prepared in DMSO at 4 mM and diluted in cell culture medium at the indicated concentrations (0.1, 0.2, 0.3, 0.4, 0.5 μM). UHCV-32 and UHCVcon-57.3 are U-2 OS human osteosar coma-derived cell lines inducibly expressing the entire open reading frame derived from the HCV H77 prototype and consensus clones, respectively. Cell viability is measured by trypan blue exclusion analysis. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 有机酸及其衍生物 |
| 类(Class) | 肽模拟物 |
| 亚类(Subclass) | 类肽-肽杂化物 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 环孢菌素 |
| 其他上位类(Alternative Parents) | 寡肽 大环内酰胺类 α氨基酸及其衍生物 叔羧酸酰胺 仲羧酸酰胺 仲醇 内酰胺类 氮杂环化合物 有机光子化合物 有机氮化合物 有机氧化物 碳氢化合物衍生物 羰基化合物 |
| 分子骨架(Molecular Framework) | 脂肪族杂单环化合物 |
| 取代基(Substituents) | 羟基苯甲酸酯 - 脂肪族杂单环化合物 - α-氨基酸或其衍生物 - α-寡肽 - 氮杂环 - 羰基 - 羧酰胺基 - 羧酸衍生物 - 环孢素骨架 - 烃衍生物 - 肟 - M-噻唑啉 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机杂环化合物 - 有机氮化合物 - 有机氧化合物 - 有机氮化合物 - 醛基 - 醛基 - 叔羧酸酰胺 |
| 描述(Description) | 该化合物属于环孢素类有机化合物。这类环状脱肽肽含有环孢素主链。 |
| 外部描述符(External Descriptors) | 暂无 |
| ALogP | 7.9 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|